1. Home
  2. VANI vs PNI Comparison

VANI vs PNI Comparison

Compare VANI & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • PNI
  • Stock Information
  • Founded
  • VANI 1998
  • PNI 2002
  • Country
  • VANI United States
  • PNI United States
  • Employees
  • VANI N/A
  • PNI N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PNI Trusts Except Educational Religious and Charitable
  • Sector
  • VANI Health Care
  • PNI Finance
  • Exchange
  • VANI Nasdaq
  • PNI Nasdaq
  • Market Cap
  • VANI 68.1M
  • PNI 75.3M
  • IPO Year
  • VANI 2014
  • PNI N/A
  • Fundamental
  • Price
  • VANI $1.26
  • PNI $6.73
  • Analyst Decision
  • VANI Strong Buy
  • PNI
  • Analyst Count
  • VANI 1
  • PNI 0
  • Target Price
  • VANI $4.00
  • PNI N/A
  • AVG Volume (30 Days)
  • VANI 66.4K
  • PNI 26.4K
  • Earning Date
  • VANI 05-13-2025
  • PNI 01-01-0001
  • Dividend Yield
  • VANI N/A
  • PNI 4.76%
  • EPS Growth
  • VANI N/A
  • PNI N/A
  • EPS
  • VANI N/A
  • PNI N/A
  • Revenue
  • VANI N/A
  • PNI N/A
  • Revenue This Year
  • VANI N/A
  • PNI N/A
  • Revenue Next Year
  • VANI N/A
  • PNI N/A
  • P/E Ratio
  • VANI N/A
  • PNI N/A
  • Revenue Growth
  • VANI N/A
  • PNI N/A
  • 52 Week Low
  • VANI $0.91
  • PNI $6.03
  • 52 Week High
  • VANI $2.09
  • PNI $7.89
  • Technical
  • Relative Strength Index (RSI)
  • VANI 77.37
  • PNI 45.23
  • Support Level
  • VANI $1.13
  • PNI $6.69
  • Resistance Level
  • VANI $1.16
  • PNI $6.76
  • Average True Range (ATR)
  • VANI 0.05
  • PNI 0.07
  • MACD
  • VANI 0.02
  • PNI -0.00
  • Stochastic Oscillator
  • VANI 92.86
  • PNI 25.93

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

About PNI Pimco New York Municipal Income Fund II of Beneficial Interest

PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.

Share on Social Networks: